Publications by authors named "Ed Curry"

Claim this Profile
A
A comprehensive clinically informed map of dependencies in cancer cells and framework for target prioritization.
Clare Pacini, Emma Duncan, Emanuel Gonçalves, James Gilbert, Shriram Bhosle, Ed Curry

Cancer Cell· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNAs as biomarkers for prostate cancer prognosis: a systematic review and a systematic reanalysis of public data.
Sharmila Rana, Gabriel N Valbuena, Ed Curry, Charlotte L Bevan, Hector C Keun

Br J Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term leaching of arsenic from pressure-treated playground structures in the northeastern United States.
Cielito M Deramos King, Celina S Dozier, Jessica L Campbell, Eric D Curry, Krystal J Godri Pollitt

Sci Total Environ· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A mathematical-descriptor of tumor-mesoscopic-structure from computed-tomography images annotates prognostic- and molecular-phenotypes of epithelial ovarian cancer.
Haonan Lu, Mubarik Arshad, Andrew Thornton, Giacomo Avesani, Paula Cunnea, Ed Curry

Nat Commun· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical value of bioelectrical properties of cancerous tissue in advanced epithelial ovarian cancer patients.
Paula Cunnea, Tommy Gorgy, Konstantinos Petkos, Sally A N Gowers, Haonan Lu, Ed Curry

Sci Rep· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-Finding Quantitative 18F-FDG PET Imaging Study with the Oral Pan-AKT Inhibitor GSK2141795 in Patients with Gynecologic Malignancies.
Hatice Gungor, Azeem Saleem, Syed Babar, Roberto Dina, Mona A El-Bahrawy, Ed Curry

J Nucl Med· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A putative biomarker signature for clinically effective AKT inhibition: correlation of in vitro, in vivo and clinical data identifies the importance of modulation of the mTORC1 pathway.
Azadeh Cheraghchi-Bashi, Christine A Parker, Ed Curry, Jean-Frederic Salazar, Hatice Gungor

Oncotarget· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Whole-genome characterization of chemoresistant ovarian cancer.
Ann-Marie Patch, Elizabeth L Christie, Dariush Etemadmoghadam, Dale W Garsed, Joshy George, Ed Curry

Nature· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosis.
Karin van Veldhoven, Silvia Polidoro, Laura Baglietto, Gianluca Severi, Carlotta Sacerdote, Ed Curry

Clin Epigenetics· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole-genome characterization of chemoresistant ovarian cancer.
Ann-Marie Patch, Elizabeth L Christie, Dariush Etemadmoghadam, Dale W Garsed, Joshy George, Ed Curry

Nature· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis